These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29199604)

  • 1. miRNA: A Diagnostic and Therapeutic Tool for Pancreatic Cancer.
    Qadir MI; Faheem A
    Crit Rev Eukaryot Gene Expr; 2017; 27(3):197-204. PubMed ID: 29199604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The State of the Art on Blood MicroRNAs in Pancreatic Ductal Adenocarcinoma.
    Gao Z; Jiang W; Zhang S; Li P
    Anal Cell Pathol (Amst); 2019; 2019():9419072. PubMed ID: 31583198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma.
    Zhao C; Zhang J; Zhang S; Yu D; Chen Y; Liu Q; Shi M; Ni C; Zhu M
    Oncol Rep; 2013 Jul; 30(1):276-84. PubMed ID: 23612862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively.
    Yu Q; Xu C; Yuan W; Wang C; Zhao P; Chen L; Ma J
    Biomed Res Int; 2017; 2017():6495867. PubMed ID: 28466015
    [No Abstract]   [Full Text] [Related]  

  • 5. MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
    Brunetti O; Russo A; Scarpa A; Santini D; Reni M; Bittoni A; Azzariti A; Aprile G; Delcuratolo S; Signorile M; Gnoni A; Palermo L; Lorusso V; Cascinu S; Silvestris N
    Oncotarget; 2015 Sep; 6(27):23323-41. PubMed ID: 26259238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
    Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
    Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: a meta-analysis.
    Chhatriya B; Mukherjee M; Ray S; Sarkar P; Chatterjee S; Nath D; Das K; Goswami S
    BMC Cancer; 2019 Dec; 19(1):1175. PubMed ID: 31795960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis.
    Akamatsu M; Makino N; Ikeda Y; Matsuda A; Ito M; Kakizaki Y; Saito Y; Ishizawa T; Kobayashi T; Furukawa T; Ueno Y
    PLoS One; 2016; 11(7):e0158669. PubMed ID: 27380024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer.
    Abue M; Yokoyama M; Shibuya R; Tamai K; Yamaguchi K; Sato I; Tanaka N; Hamada S; Shimosegawa T; Sugamura K; Satoh K
    Int J Oncol; 2015 Feb; 46(2):539-47. PubMed ID: 25384963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
    Sun B; Liu X; Gao Y; Li L; Dong Z
    Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Alemar B; Izetti P; Gregório C; Macedo GS; Castro MA; Osvaldt AB; Matte U; Ashton-Prolla P
    Pancreas; 2016 Jan; 45(1):84-92. PubMed ID: 26262588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA‑539 inhibits cell proliferation, colony formation and invasion in pancreatic ductal adenocarcinoma by directly targeting IGF‑1R.
    Lin Y; Rong L; Zhao J; Lin R; Li S
    Mol Med Rep; 2018 Aug; 18(2):1804-1811. PubMed ID: 29901181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNAs as diagnostic biomarkers for pancreatic cancer.
    Le Large TY; Meijer LL; Prado MM; Kazemier G; Frampton AE; Giovannetti E
    Expert Rev Mol Diagn; 2015; 15(12):1525-9. PubMed ID: 26567751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.
    Szafranska AE; Davison TS; John J; Cannon T; Sipos B; Maghnouj A; Labourier E; Hahn SA
    Oncogene; 2007 Jun; 26(30):4442-52. PubMed ID: 17237814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells.
    Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH
    PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of miR-194 contributes to tumor growth and progression in pancreatic ductal adenocarcinoma.
    Zhang J; Zhao CY; Zhang SH; Yu DH; Chen Y; Liu QH; Shi M; Ni CR; Zhu MH
    Oncol Rep; 2014 Mar; 31(3):1157-64. PubMed ID: 24398877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.
    Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J
    Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
    Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
    Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
    Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
    Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.